A National Conversation: Should COVID Vaccines be Mandatory on College Campuses?

Opening Remarks:

Julio Frenk, M.D., M.P.H., Ph.D.

President
University of Miami
(View biography)

Moderator:

Roy E. Weiss, M.D., Ph.D.

Chief Medical Officer for COVID-19
Chair, Department of Medicine
University of Miami Miller School of Medicine
(View biography)

Panel:

Carlos del Rio, M.D.

Executive Associate Dean
Distinguished Professor of Medicine in the Division of Infectious Diseases
Professor of Epidemiology and Global Health, Rollins School of Public Health
Emory University School of Medicine

Carlos del Rio, M.D. is a Distinguished Professor of Medicine in the Division of Infectious Diseases at Emory University School of Medicine and Executive Associate Dean for Emory at Grady. He is also professor of Global Health and professor of Epidemiology at the Rollins School of Public Health. He is co-director of the Emory Center for AIDS Research (CFAR) and co-PI of the Emory-CDC HIV Clinical Trials Unit and the Emory Vaccine and Treatment Evaluation Unit. Dr. del Rio is a native of Mexico, where he attended medical school at Universidad La Salle. He did his internal medicine and infectious diseases residencies at Emory University. He was chief of the Emory Medical Service at Grady Memorial Hospital and chair of the Hubert Department of Global Health. Dr. del Rio’s research focuses on the early diagnosis, access to care, engagement in care, compliance with antiretrovirals, and the prevention of HIV infection. He has worked for more than a decade with hard-to-reach populations, including substance users, to improve outcomes of those infected with HIV and to prevent infection with those at risk. He is also interested in the translation of research findings into practice and policy. Dr. del Rio was a member of the WHO Influenza A(H1N1) Clinical Advisory Group and of the CDC Influenza A(H1N1) Task Force during the 2009 pandemic. He was elected in 2013 to the U.S. National Academy of Medicine; and in 2020, he was elected as the international secretary.  He is the chair of the Scientific Advisory Board of PEPFAR, member of the National Institute on Drug Abuse (NIDA) Scientific Council, and member of UNAIDS Scientific and Technical Advisory Committee. During the COVID-19 pandemic, Dr. del Rio has been a leader locally and nationally, doing research, developing policies, writing scientific publications, and making countess media appearances. He has advised municipal, state, and national leaders including Atlanta Mayor Keisha Lance Bottoms, as well as Tyler Perry Studios, the NCAA, the USTA, Delta Air Lines, Truist Bank, the Atlanta Symphony Orchestra, and the Atlanta Opera among others. He also serves on the national advisory committee of the COVID Collaborative, which focuses on developing consensus recommendations and engaging with U.S. leaders on effective policy and coronavirus response. Lastly, Dr. del Rio is an investigator on the Moderna COVID-19 vaccine clinical trial as well as on the ACTT Studies that led to the approval of Remdesivir among other drugs.

Kenneth W. Goodman, Ph.D.

Founder and Director, Miller School of Medicine Institute for Bioethics and Health Policy
Director, Ethics Programs
University of Miami

Kenneth W. Goodman, Ph.D., FACMI, FACE, is founder and director of the University of Miami Miller School of Medicine’s Institute for Bioethics and Health Policy and director of the university’s ethics programs. The institute has been designated a World Health Organization Collaborating Center in Ethics and Global Health Policy, the only one in the United States. Goodman’s recent work has included contributions to COVID-19 crisis standards of care and drug and vaccine allocation policies. He is a professor of Medicine at the University of Miami with joint appointments in the Department of Philosophy, School of Nursing and Health Studies, and Department of Public Health Sciences.

Lainie Friedman Ross, M.D., Ph.D.

Carolyn and Matthew Bucksbaum Professor of Clinical Ethics
Associate Director, MacLean Center for Clinical Medical Ethics
University of Chicago

Lainie Friedman Ross, M.D., Ph.D., is the Carolyn and Matthew Bucksbaum Professor of Clinical Medical Ethics at the University of Chicago and a professor in the Departments of Pediatrics, Medicine, Surgery, and the College. She is also director of the Research Ethics Consultation Service, associate director of the MacLean Center for Clinical Medical Ethics, and co-director of Institute for Translational Medicine at the University of Chicago. Dr. Ross earned her AB from the School of Public and International Affairs at Princeton University. She earned an M.D. from the University of Pennsylvania School of Medicine and a Ph.D. in philosophy from Yale University. She trained at the Children’s Hospital of Philadelphia and at Babies Hospital of Columbia University, now the Morgan Stanley Children’s Hospital of New York-Presbyterian. Dr. Ross is a primary care pediatrician at the University of Chicago Comer Children’s Hospital. Her research portfolio focuses on ethical and policy issues in pediatrics, genetics, organ transplantation, and human-subjects protections. She has published four books and has a fifth in press as well as more than 200 peer-reviewed articles. She was recently awarded a National Library of Medicine grant from the National Institutes of Health to examine, “Am I my sibling’s keeper? Sibling Obligations in Health Care.”

Closing Remarks:

Henri R. Ford, M.D., M.H.A.

Dean and Chief Academic Officer
University of Miami Miller School of Medicine
(View biography)